JustPharmaReports.com
Over the past 20 years, JustPharma's analyst has written more than 50 major reports and numerous articles for many leading trade publishers. Those on global pricing and reimbursement (including the first ever journal dedicated to P&R, Pharma Pricing Review), European integration, parallel trade, wholesale and retail distribution, hospital drug procurement, orphan drugs, generics and Japan have become industry standards. These topics will be further developed and others added by the author, but only from now under the justpharmareports label. If you are tired and confused with over-complicated Powerpoint presentations that tend to lose all meaning over time, you will welcome the clear, succinct and eminently readable style of justpharmareports, where the emphasis is on imparting understanding. Every report deals with the subject comprehensively in a neutral, fact-based manner. Each is based on up-to-the-minute research by the author - largely primary research in the field - among leading experts on the topic concerned. All have a logical layout and are clearly indexed.
As well as major reports you will find occasional short briefing notes and articles on topical subjects.
|

|
List of reports from JustPharmaReports.com
Market Access Taiwan
11/1/2012 | published by: JustPharmaReports.com
... be modified and the importance of health technology assessment (HTA) reaffirmed. The Cross-Strait Co-operation Agreement on Medicine and Public Health Affairs with mainland China might be of even greater significance in the longer term as ...
|
more...
|
$1,420.00
|
Biosimilars: Current Situation & Future Prospects, Worldwide
3/1/2012 | published by: JustPharmaReports.com
... biologics market expected to lose some degree of protection by 2019. All major countries now make provision for an abbreviated biosimilar development and regulatory pathway. Funds are flowing into the sector and many new partnership ...
|
more...
|
$3,000.00
|
Pharmaceutical Pricing & Distribution in Japan, 2010 Update
10/1/2011 | published by: JustPharmaReports.com
... optimise market access and life cycle management into 60 pages and offers tremendous value. Completely updated, it explains all the latest changes to the NHI pricing rules, including the important new price premium for developing ...
|
more...
|
$760.00
|
|
|
$2,300.00
|
|
|
$1,380.00
|
|
|
$2,320.00
|
Distribution and Patient Support for Speciality Medicines in Europe
9/1/2009 | published by: JustPharmaReports.com
... and handling, with help with dosage administration, close monitoring and ongoing support for the patient needed. Manufacturers of speciality medicines seek a competitive advantage through distribution optimisation, including responsive, efficient and cost effective logistics, better ...
|
more...
|
$1,050.00
|
|
|
$1,600.00
|
|
|
$1,350.00
|
Pharmacy Liberalisation in Europe: Prospects and Implications
9/1/2008 | published by: JustPharmaReports.com
... the arguments put to it forcefully by the European Commission and by DocMorris, revolutionary reform among industry’s main customer group, the community pharmacist, in several of the main countries, including 4 of the EU-5, will ...
|
more...
|
$905.00
|
Access to Hospital Pharmaceutical Markets in the United Kingdom
8/1/2008 | published by: JustPharmaReports.com
... products also unable to get established for maintenance therapy in the community without hospital recommendation first. Though the processes for achieving hospital usage are very different to the reimbursed GP/community pharmacy sector, they have been ...
|
more...
|
$1,350.00
|
|
|
$2,700.00
|
|
Join Alert Me now!Receive bi-weekly email alerts on new market research Sign up today!
|